Patients are being recruited for a trial to determine whether chemicals in cannabis can slow the impact of multiple sclerosis. Evidence suggests the drug may relieve symptoms but the three-year national trial is also to determine whether it slows the disease’s...
Abstract Effective therapeutic options for patients living with chronic pain are limited. The pain relieving effect of cannabinoids remains unclear. A systematic review of RCTs examining cannabinoids in treatment of chronic non-cancer pain was conducted according to...
2967 Mission Street (Between 25 & 26th St) San Francisco, CA 94110 (415) 550-4004
Scientific consensus on the role of marijuana in psychological disorders is still lacking, after hundreds of years of speculation and study. Recent evidence of dysregulation of the body’s endocannabinoid system in schizophrenics is beginning to shed new light on...
June 20th, 2011 By: Paul Armentano, NORML Deputy Director The combined administration of the plant cannabinoids THC and CBD (cannabidiol) provide neuroprotection in rat models of Huntington’s Disease (HD), according to experimental data to be published in theJournal...
